IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $77,000 | -27.4% | 13,965 | +12.2% | 0.01% | -25.0% |
| Q4 2021 | $106,000 | -12.4% | 12,450 | -10.7% | 0.02% | -20.0% |
| Q3 2021 | $121,000 | -18.2% | 13,942 | -0.2% | 0.02% | -23.1% |
| Q2 2021 | $148,000 | +1.4% | 13,967 | +53.6% | 0.03% | -10.3% |
| Q1 2021 | $146,000 | -20.7% | 9,092 | +128.0% | 0.03% | -25.6% |
| Q4 2020 | $184,000 | +60.0% | 3,987 | +21.6% | 0.04% | +39.3% |
| Q3 2020 | $115,000 | – | 3,280 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 7,510,412 | $264,291,000 | 6.36% |
| Ghost Tree Capital, LLC | 525,000 | $18,475,000 | 5.34% |
| Pinz Capital Management, LP | 199,100 | $7,006,000 | 2.56% |
| ACUTA CAPITAL PARTNERS, LLC | 250,000 | $8,798,000 | 2.39% |
| BVF INC/IL | 1,198,427 | $42,173,000 | 2.30% |
| Cormorant Asset Management, LP | 1,637,951 | $57,639,000 | 2.22% |
| Vivo Capital, LLC | 1,042,460 | $36,684,000 | 2.12% |
| Parkman Healthcare Partners LLC | 150,151 | $5,284,000 | 1.40% |
| MANGROVE PARTNERS IM, LLC | 230,307 | $8,105,000 | 1.02% |
| Ikarian Capital, LLC | 321,887 | $11,328,000 | 0.82% |